Literature DB >> 467254

[Serum thyroglobulin estimation for follow-up of patients with thyroid carcinoma (author's transl)].

H Botsch, E Schulz, B Lochner.   

Abstract

Thyroglobulin concentrations were determined radioimmunologically in the sera of 53 patients operated for thyroid carcinoma. 37 patients without metastases or recurrence had either very low (up to maximally 15 ng/ml) or non-demonstrable thyroglobulin concentrations, whereas 16 patients with metastases showed values of more than 40 ng/ml up to maximal values of more than 1000 ng/ml. In the majority of patients follow-up controls, in part up to 2 years, were performed. A far-reaching conformity of thyroglobulin concentrations with scintigraphic or clinical findings of metastases was shown. Thyroglobulin estimation in operated thyroid cancer patients is thus an important contribution to the aftercare.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 467254     DOI: 10.1055/s-0028-1129040

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  6 in total

1.  Evidence for autonomous thyroglobulin release from euthyroid and hyperthyroid nodular goiter--thyroglobulin, a possible helpful parameter in diagnosis of non-malignant thyroid disorders.

Authors:  R Gärtner; A Hainzinger; K Horn; R C Pickardt
Journal:  Klin Wochenschr       Date:  1983-08-01

Review 2.  [Significance of thyroglobulin as a tumor marker in the serum of patients with differentiated thyroid carcinoma: longitudinal and cross-sectional studies (author's transl)].

Authors:  H Schatz; S Grebe; E Mäser; J Teuber; W Horn; O Schröder; C Schatz
Journal:  Klin Wochenschr       Date:  1982-05-03

3.  [Long-term observation of 15 patients with differentiated thyroid cancer and elevated plasma thyroglobulin levels of unclear origin].

Authors:  H P Stumpf; M Hüfner; H J Hermann; B Kimmig
Journal:  Klin Wochenschr       Date:  1984-05-02

4.  Immunoreactive thyroglobulin in sera and saliva of patients with various thyroid disorders: role of autoantibodies.

Authors:  A J Van Herle; P D Rosenblit; T L Van Herle; P Van Herle; M Greipel; K Kellett
Journal:  J Endocrinol Invest       Date:  1989-03       Impact factor: 4.256

5.  Serum thyroglobulin levels in patients with well-differentiated thyroid cancer during suppression therapy: study on 429 patients.

Authors:  M E Girelli; B Busnardo; R Amerio; G Scotton; D Casara; C Betterle; M Piccolo; M R Pelizzo
Journal:  Eur J Nucl Med       Date:  1985

6.  Low levels of serum thyroglobulin after withdrawal of thyroid suppression therapy in the follow up of differentiated thyroid carcinoma.

Authors:  A J Brendel; B Lambert; M Guyot; R Jeandot; H Dubourg; P Roger; S Wynchauk; G Manciet; G Lefort
Journal:  Eur J Nucl Med       Date:  1990
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.